Not applicableStudy completedNCT06617390
What this trial is testing
Real-world Treatment Patterns and Outcomes in Chinese Advanced NSCLC Patients Who Previously Received at Least 2 Line Treatments
Who this might be right for
Non-small Cell Lung Cancer (NSCLC)
Daiichi Sankyo 1,041